Maryam Lustberg, MD, MPH

Maryam Lustberg, MD, MPH, is director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and chief of breast medical oncology at Yale Cancer Center.

Articles by Maryam Lustberg, MD, MPH

DESTINY-Breast09: Will T-DXd + Pertuzumab Replace THP in First-Line HER2+ mBC?

Maryam Lustberg, MD, MPHHER2 Breast Cancer | June 4, 2025

Dr. Lustberg discusses DESTINY-Breast09 and the potential shift to T-DXd + pertuzumab in HER2+ mBC first-line treatment.